1. Korean Society for the Study of Obesity. Metabolic syndrome-pathological molecular biolocy 2005;Seoul: Euihakmunhwasa. by Matsuzawa. (Korean version).
2. Kim JY, Shin HW, Jeong IK, Yoo HJ, et al. Correlation among adiponectin, leptin, ghrelin, insulin resistance and cardiovascular risk factors according to the degree of obesity. Korean J of Internal Medicine 2005;69:631-641.
3. Matsuzawa Y. Pathophysiology and molecular mechanisms of visceral fat syndrome. Diabetes Metab Rev 1997;13:3-13.
4. Raven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
5. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999;83:25-29.
6. Miyazaki Y, Mahankali A, Matsuda M, Mahankali S, Hardies J, Cusi K, Mandarino LJ, DeFronzo RA. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 2002;87:2784-2791.
7. Lee SY, Park HS, Kim DJ, Han JH, Kim MS, Cho GJ, Kim DY, Kwon HS, Kim SR, Lee CB, Oh SJ, Park CY, Yoo HJ. Appro priate waist circumference cutoff points for central obesity as main component of the new International Diabetes Federation definition in Korean adults. Diabetes Res Clin Pract 2007;75:72-80. (accepted, 24 April 2006).
8. Park HS, Park CY, Oh SW, Yoo HJ. Prevalence of Obesity and Metabolic Syndrome in Korean Adults. Obesity Reviews 2007;(in press).
9. Korean Society for the Study of Obesity. Metabolic syndrome practical guide 2005;Seoul: Euihakmunhwasa.